NuSkin Enterprises (NUS) Stock News, Jan-Jul 2025

Nu Skin (NYSE: NUS) has announced a significant relaunch of its ageLOC® Tru Face® skincare line, focusing on sustainable packaging innovations while maintaining product efficacy. The initiative aims to save 515,000 pounds of glass and plastic and eliminate 572 tons of emissions annually by the end of 2025.

The refreshed line includes notable products such as the Transforming Gel Cream, showing 100% user satisfaction in hydration within two weeks, and the Refining Toner with up to 47% improvement in tone evenness. Key sustainability features include refillable systems, recycled materials usage, and innovative packaging solutions like the TFEU refill pouch that reduces material use by 96.8%.

Nu Skin Enterprises (NYSE: NUS) has appointed James Winett, managing member of SIZE Advisory Group, to its board of directors following a shareholder election. Winett brings significant expertise in strategic planning, operations, and finance from his consulting background. He co-founded SIZE Advisory Group in 2020, providing consulting services to companies of various sizes. His previous experience includes founding DPAA Group, Inc. (2014-2023) and working at Price Waterhouse LLP in audit, assurance, and corporate recovery roles. Winett holds an MBA from Northwestern University's Kellogg School of Management and a BS in Accountancy from the University of Illinois. The company expects his expertise to benefit both Nu Skin's main operations and its Rhyz businesses, particularly in corporate transactions and startup advisory.

Nu Skin Enterprises (NUS) reported Q1 2025 revenue of $364.5 million, reaching the high end of guidance despite a 12.7% year-over-year decline. EPS was $2.14, or $0.23 excluding Mavely gain and other charges. The company saw growth in Latin America and Rhyz manufacturing but faced challenges in premium beauty due to inflation and tariffs. Key metrics showed declines with customers down 11%, paid affiliates down 15%, and sales leaders down 20%. The company reduced debt by $155 million, reaching its lowest level in 10 years. For Q2 2025, Nu Skin projects revenue of $355-390 million with EPS of $0.20-0.30. Full-year 2025 guidance maintained at $1.48-1.62 billion in revenue and EPS of $2.80-3.20 (or $0.90-1.30 excluding Mavely gain).

Nu Skin Enterprises (NYSE: NUS) has announced that its board of directors has declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on June 11, 2025, to shareholders who are on record as of May 30, 2025. This dividend declaration represents the company's continued commitment to returning value to shareholders through regular dividend payments.

Nu Skin Enterprises (NYSE: NUS) has scheduled the release of its first quarter 2025 financial results after market close on Thursday, May 8. The company's management team will host a conference call with investors at 5 p.m. ET on the same day to discuss quarterly performance and upcoming business initiatives.

The financial presentation and conference call will be accessible via webcast on the company's investor relations website at ir.nuskin.com. A replay option will remain available through Thursday, May 22.

Nu Skin Enterprises (NYSE: NUS) reported Q4 2024 revenue of $445.6 million, down 8.8% year-over-year but above company guidance, with a 4.1% FX impact. Q4 EPS was $(0.73), or $0.38 excluding restructuring charges. Full-year 2024 revenue reached $1.73 billion, declining 12% with a 3.8% FX impact.

The company's Rhyz segment showed strong growth, with Q4 revenue of $83.1 million (+27.7%) and full-year revenue of $286.6 million (+32.3%). Customer base decreased 15% to 831,972, with paid affiliates down 13% and sales leaders declining 16%.

For 2025, Nu Skin projects revenue between $1.48-$1.62 billion, expecting a 3% FX headwind. Q1 2025 revenue guidance is $345-365 million, with EPS forecast of $2.65-$2.75, or $0.10-$0.20 excluding the Mavely transaction gain.

Nu Skin Enterprises (NYSE: NUS) has announced that its board of directors has declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on March 5, 2025, to shareholders of record as of February 24, 2025.

Nu Skin Enterprises (NYSE: NUS) has announced that its Q4 2024 preliminary revenue is at the high end of the company's guidance range. This announcement comes ahead of its presentation at the ICR Conference on Jan. 14, where President and CEO Ryan Napierski, along with CFO James Thomas, will discuss the company's strategy and performance, including the recent strategic acquisition of Mavely for $250 million. The presentation will be webcast live at 3 p.m. ET on the company's investor relations page, with an archive available through Jan. 28.

Nu Skin will release its full Q4 and full year 2024 financial results after market close on Feb. 13. Following the release, the management team will host a conference call at 5 p.m. ET, which will also be webcast live on the investor relations page. A replay will be accessible through Feb. 27.

Nu Skin Enterprises (NYSE: NUS) announced that its subsidiary Rhyz Inc. has completed a strategic transaction with Later, selling its Mavely affiliate marketing technology platform for approximately $250 million in cash and a minority equity stake in the combined Later/Mavely business. Of this amount, $33 million will be distributed to other Mavely equity holders.

The transaction represents a five-times return on Nu Skin's investment since acquiring Mavely in 2021. Mavely will continue providing technology and social commerce capabilities to support Nu Skin's affiliate marketing business. The company plans to use the proceeds to reduce debt, fund innovation, and repurchase shares under its existing stock buyback program.